vs
Side-by-side financial comparison of HARROW, INC. (HROW) and ServisFirst Bancshares, Inc. (SFBS). Click either name above to swap in a different company.
ServisFirst Bancshares, Inc. is the larger business by last-quarter revenue ($159.0M vs $89.1M, roughly 1.8× HARROW, INC.). ServisFirst Bancshares, Inc. runs the higher net margin — 52.2% vs 7.4%, a 44.7% gap on every dollar of revenue. Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 17.7%).
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
ServisFirst Bancshares, Inc. is a U.S.-based bank holding company operating full-service banking locations primarily across the Southeastern United States. It offers a full suite of commercial banking, consumer banking, wealth management, and mortgage lending services to small and medium-sized businesses, professional clients, and individual consumers.
HROW vs SFBS — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $89.1M | $159.0M |
| Net Profit | $6.6M | $83.0M |
| Gross Margin | 79.3% | — |
| Operating Margin | 17.5% | — |
| Net Margin | 7.4% | 52.2% |
| Revenue YoY | 33.3% | — |
| Net Profit YoY | -2.2% | 31.2% |
| EPS (diluted) | $0.20 | $1.52 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $159.0M | ||
| Q4 25 | $89.1M | $162.2M | ||
| Q3 25 | $71.6M | $136.3M | ||
| Q2 25 | $63.7M | $132.1M | ||
| Q1 25 | $47.8M | $131.8M | ||
| Q4 24 | $66.8M | $131.9M | ||
| Q3 24 | $49.3M | $123.7M | ||
| Q2 24 | $48.9M | $114.8M |
| Q1 26 | — | $83.0M | ||
| Q4 25 | $6.6M | $86.4M | ||
| Q3 25 | $1.0M | $65.6M | ||
| Q2 25 | $5.0M | $61.4M | ||
| Q1 25 | $-17.8M | $63.2M | ||
| Q4 24 | $6.8M | $65.2M | ||
| Q3 24 | $-4.2M | $59.9M | ||
| Q2 24 | $-6.5M | $52.1M |
| Q1 26 | — | — | ||
| Q4 25 | 79.3% | — | ||
| Q3 25 | 75.3% | — | ||
| Q2 25 | 74.5% | — | ||
| Q1 25 | 67.5% | — | ||
| Q4 24 | 78.8% | — | ||
| Q3 24 | 75.6% | — | ||
| Q2 24 | 74.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | 17.5% | 66.3% | ||
| Q3 25 | 20.6% | 57.8% | ||
| Q2 25 | 17.9% | 58.0% | ||
| Q1 25 | -23.5% | 60.0% | ||
| Q4 24 | 19.3% | 60.2% | ||
| Q3 24 | 2.7% | 58.5% | ||
| Q2 24 | 3.1% | 58.0% |
| Q1 26 | — | 52.2% | ||
| Q4 25 | 7.4% | 59.0% | ||
| Q3 25 | 1.4% | 48.1% | ||
| Q2 25 | 7.8% | 46.5% | ||
| Q1 25 | -37.2% | 48.0% | ||
| Q4 24 | 10.1% | 52.9% | ||
| Q3 24 | -8.6% | 48.4% | ||
| Q2 24 | -13.2% | 45.4% |
| Q1 26 | — | $1.52 | ||
| Q4 25 | $0.20 | $1.58 | ||
| Q3 25 | $0.03 | $1.20 | ||
| Q2 25 | $0.13 | $1.12 | ||
| Q1 25 | $-0.50 | $1.16 | ||
| Q4 24 | $0.19 | $1.19 | ||
| Q3 24 | $-0.12 | $1.10 | ||
| Q2 24 | $-0.18 | $0.95 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $72.9M | $1.8B |
| Total DebtLower is stronger | $250.0M | — |
| Stockholders' EquityBook value | $52.4M | $1.9B |
| Total Assets | $399.5M | $18.2B |
| Debt / EquityLower = less leverage | 4.77× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $1.8B | ||
| Q4 25 | $72.9M | — | ||
| Q3 25 | $74.3M | — | ||
| Q2 25 | $53.0M | — | ||
| Q1 25 | $66.7M | — | ||
| Q4 24 | $47.2M | — | ||
| Q3 24 | $72.6M | — | ||
| Q2 24 | $71.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | $250.0M | — | ||
| Q3 25 | $347.2M | — | ||
| Q2 25 | $250.6M | — | ||
| Q1 25 | $256.9M | — | ||
| Q4 24 | $262.7M | — | ||
| Q3 24 | $230.7M | — | ||
| Q2 24 | $236.3M | — |
| Q1 26 | — | $1.9B | ||
| Q4 25 | $52.4M | $1.8B | ||
| Q3 25 | $47.0M | $1.8B | ||
| Q2 25 | $49.7M | $1.7B | ||
| Q1 25 | $56.5M | $1.7B | ||
| Q4 24 | $69.7M | $1.6B | ||
| Q3 24 | $58.0M | $1.6B | ||
| Q2 24 | $58.5M | $1.5B |
| Q1 26 | — | $18.2B | ||
| Q4 25 | $399.5M | $17.7B | ||
| Q3 25 | $363.1M | $17.6B | ||
| Q2 25 | $345.0M | $17.4B | ||
| Q1 25 | $364.2M | $18.6B | ||
| Q4 24 | $389.0M | $17.4B | ||
| Q3 24 | $351.5M | $16.4B | ||
| Q2 24 | $306.6M | $16.0B |
| Q1 26 | — | — | ||
| Q4 25 | 4.77× | — | ||
| Q3 25 | 7.39× | — | ||
| Q2 25 | 5.05× | — | ||
| Q1 25 | 4.55× | — | ||
| Q4 24 | 3.77× | — | ||
| Q3 24 | 3.98× | — | ||
| Q2 24 | 4.04× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.4M | — |
| Free Cash FlowOCF − Capex | $8.1M | — |
| FCF MarginFCF / Revenue | 9.1% | — |
| Capex IntensityCapex / Revenue | 0.4% | — |
| Cash ConversionOCF / Net Profit | 1.27× | — |
| TTM Free Cash FlowTrailing 4 quarters | $43.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $8.4M | $355.2M | ||
| Q3 25 | $16.6M | $140.9M | ||
| Q2 25 | $-803.0K | $67.6M | ||
| Q1 25 | $19.7M | $48.0M | ||
| Q4 24 | $-17.8M | $252.9M | ||
| Q3 24 | $3.0M | $84.0M | ||
| Q2 24 | $-2.7M | $48.3M |
| Q1 26 | — | — | ||
| Q4 25 | $8.1M | — | ||
| Q3 25 | $16.4M | — | ||
| Q2 25 | $-969.0K | — | ||
| Q1 25 | $19.5M | — | ||
| Q4 24 | $-18.3M | — | ||
| Q3 24 | $2.3M | — | ||
| Q2 24 | $-3.1M | — |
| Q1 26 | — | — | ||
| Q4 25 | 9.1% | — | ||
| Q3 25 | 22.9% | — | ||
| Q2 25 | -1.5% | — | ||
| Q1 25 | 40.8% | — | ||
| Q4 24 | -27.4% | — | ||
| Q3 24 | 4.8% | — | ||
| Q2 24 | -6.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.8% | — | ||
| Q3 24 | 1.2% | — | ||
| Q2 24 | 0.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.27× | 4.11× | ||
| Q3 25 | 16.26× | 2.15× | ||
| Q2 25 | -0.16× | 1.10× | ||
| Q1 25 | — | 0.76× | ||
| Q4 24 | -2.62× | 3.88× | ||
| Q3 24 | — | 1.40× | ||
| Q2 24 | — | 0.93× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HROW
Segment breakdown not available.
SFBS
| Net Interest Income | $148.1M | 93% |
| Noninterest Income | $10.8M | 7% |
